The tl;dr Pharmacy Journal Club: Oral Azacitidine for Acute Myeloid Leukemia (The QUAZAR Trial)

Did our recent pediatric ALL post get your wheels turning about leukemia and oncology therapies? Are you eager to learn more about how we treat variations of leukemia while also honing your journal club skills? Great! Check out this latest tl;dr journal club about a new (pretty game changing) oral maintenance therapy for adult AML.

Clinical, Pharmacy School, Practice, ResidencyStephanie KujawskiOctober 19, 2021AML treatment, oral azacitidine hypomethylating agent, onureg new FDA drug approval, AML treatments other than stem cell transplant, how is AML treated, oral chemotherapy for AML